Humanisation and pre-clinical validation of a therapeutic anti-cancer antibody

Project: Research

Status	Finished
Effective start/end date	1/01/15 → 31/12/17

Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours
Yan, H., Vail, M. E., Hii, L., Guo, N., McMurrick, P. J., Oliva, K., Wilkins, S., Saha, N., Nikolov, D. B., Lee, F. T., Scott, A. M. & Janes, P. W., 1 Jul 2022, In: Cancers. 14, 13, 13 p., 3171.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth
Atapattu, L., Saha, N., Chheang, C., Eissman, M. F., Xu, K., Vail, M. E., Hii, L., Llerena, C., Liu, Z., Horvay, K., Abud, H. E., Kusebauch, U., Moritz, R. L., Ding, B-S., Cao, Z., Rafii, S., Ernst, M., Scott, A. M., Nikolov, D. B., Lackmann, M., & 1 othersJanes, P. W., 8 Aug 2016, In: Journal of Experimental Medicine. 213, 9, p. 1741-1757 17 p.
Research output: Contribution to journal › Article › Research › peer-review

40 Citations (Scopus)

Project Details